India · Delayed Price · Currency is INR Sarda Proteins Statistics
Total Valuation
Sarda Proteins has a market cap or net worth of INR 249.05 million. The enterprise value is 248.71 million.
| Market Cap | 249.05M |
| Enterprise Value | 248.71M |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Sarda Proteins has 1.73 million shares outstanding. The number of shares has increased by 7.75% in one year.
| Current Share Class | 1.73M |
| Shares Outstanding | 1.73M |
| Shares Change (YoY) | +7.75% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | 34.27% |
| Owned by Institutions (%) | 3.46% |
| Float | 1.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.71 |
| PB Ratio | 10.47 |
| P/TBV Ratio | 10.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -60.93 |
| EV / Sales | 0.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -10.38% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 117.15M |
| Profits Per Employee | -1.36M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Sarda Proteins has paid 151,000 in taxes.
| Income Tax | 151,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.40% in the last 52 weeks. The beta is -2.74, so Sarda Proteins's price volatility has been lower than the market average.
| Beta (5Y) | -2.74 |
| 52-Week Price Change | +47.40% |
| 50-Day Moving Average | 117.39 |
| 200-Day Moving Average | 66.94 |
| Relative Strength Index (RSI) | 99.53 |
| Average Volume (20 Days) | 2,163 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sarda Proteins had revenue of INR 351.46 million and -4.08 million in losses. Loss per share was -2.41.
| Revenue | 351.46M |
| Gross Profit | -504,000 |
| Operating Income | -3.95M |
| Pretax Income | -3.93M |
| Net Income | -4.08M |
| EBITDA | n/a |
| EBIT | -3.95M |
| Loss Per Share | -2.41 |
Balance Sheet
The company has 338,000 in cash and n/a in debt, giving a net cash position of 338,000 or 0.20 per share.
| Cash & Cash Equivalents | 338,000 |
| Total Debt | n/a |
| Net Cash | 338,000 |
| Net Cash Per Share | 0.20 |
| Equity (Book Value) | 23.78M |
| Book Value Per Share | 13.76 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -0.14%, with operating and profit margins of -1.12% and -1.16%.
| Gross Margin | -0.14% |
| Operating Margin | -1.12% |
| Pretax Margin | -1.12% |
| Profit Margin | -1.16% |
| EBITDA Margin | n/a |
| EBIT Margin | -1.12% |
| FCF Margin | n/a |
Dividends & Yields
Sarda Proteins does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.75% |
| Shareholder Yield | n/a |
| Earnings Yield | -1.64% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |